Suppression of MMP-9 by doxycycline in brain arteriovenous malformations

BACKGROUND: The primary aim of this study is to demonstrate the feasibility of utilizing doxycycline to suppress matrix metalloproteinase-9 (MMP-9) in brain arteriovenous malformations (AVMs). METHODS: Ex-vivo treatment of AVM tissues: Intact AVM tissues were treated with doxycycline for 48 hours. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashimoto, Tomoki, Matsumoto, Melissa M, Li, Jenny F, Lawton, Michael T, Young, William L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC547916/
https://www.ncbi.nlm.nih.gov/pubmed/15667660
http://dx.doi.org/10.1186/1471-2377-5-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC547916/
https://www.ncbi.nlm.nih.gov/pubmed/15667660
http://dx.doi.org/10.1186/1471-2377-5-1

Ejemplares similares